Elevation Wealth Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.8K Buy
341
+149
+78% +$11.1K 0.01% 621
2026
Q2
$13.8K Buy
192
+36
+23% +$3.39K ﹤0.01% 706
2026
Q1
$18.4K Buy
156
+30
+24% +$3.71K 0.01% 397
2025
Q4
$15.9K Sell
126
-1,010
-89% -$132K 0.01% 415
2025
Q3
$166K Buy
1,136
+34
+3% +$5.14K 0.06% 129
2025
Q2
$172K Buy
1,102
+1
+0.1% +$159 0.07% 122
2025
Q1
$181K Hold
1,101
– – 0.08% 117
2024
Q4
$179K Hold
1,101
– – 0.08% 122
2024
Q3
$215K Buy
1,101
+1
+0.1% +$184 0.09% 109
2024
Q2
$191K Hold
1,100
– – 0.09% 112
2024
Q1
$186K Hold
1,100
– – 0.09% 112
2023
Q4
$191K Hold
1,100
– – 0.11% 106
2023
Q3
$191K Hold
1,100
– – 0.17% 63
2023
Q2
$189K Sell
1,100
-238
-18% -$41.1K 0.16% 63
2023
Q1
$223K Buy
+1,338
New +$219K 0.2% 58

Other funds holding ZTS

Elevation Wealth Partners's ZTS Position: Q3 2026 in Review

Elevation Wealth Partners increased its Zoetis (ZTS) stake by 78% in Q3 2026, buying an estimated $11.1K and bringing the position to 341 shares worth $23.8K. The position accounts for 0.01% of the portfolio, ranked #621.

Elevation Wealth Partners first reported a position in ZTS in Q1 2023 and has held it in 15 quarters since. The position peaked at $223K in Q1 2023. 396 funds tracked by Wall St. Rank hold ZTS as of Q3 2026.

  • Elevation Wealth Partners held 341 shares of Zoetis worth $23.8K as of Q3 2026.
  • Elevation Wealth Partners bought 149 Zoetis shares in Q3 2026, an estimated $11.1K.
  • Zoetis made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #621 holding.
  • Elevation Wealth Partners first reported a position in Zoetis in Q1 2023 and has held it in 15 quarters since.
  • Elevation Wealth Partners's Zoetis position peaked at $223K in Q1 2023.
  • 396 funds tracked by Wall St. Rank held Zoetis as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.